- Body composition is associated with nintedanib-related diarrhoea: risk stratification in idiopathic pulmonary fibrosis. [Journal Article]Thorax. 2026 Aug 07. [Online ahead of print]T
- Diarrhoea is the primary cause of nintedanib discontinuation in idiopathic pulmonary fibrosis. We investigated predictors in 100 prospective patients; 46% experienced diarrhoea, defined as common terminology criteria for adverse events V.5.0 grade ≥1. In a multivariable model (area under the curve 0.9056), lower standardised body surface area (adjusted OR 0.20, 95% CI 0.06 to 0.55, p=0.004) emerg…
- Publisher Full Text (DOI)
- Optimal timing, duration and sequencing of therapy for progressive pulmonary fibrosis: the urgent need to move beyond the 'wait-to-fail' paradigm. [Journal Article]Thorax. 2026 Aug 07. [Online ahead of print]T
- Publisher Full Text (DOI)
- Visible mould and blood inflammatory phenotypes of asthma in adults: the CONSTANCES cohort. [Journal Article]Thorax. 2026 Aug 07. [Online ahead of print]T
- Studying the associations between indoor mould contamination and blood inflammatory phenotypes may provide further insight into the mechanisms by which this environmental factor affects asthma.Among 1870 adults with current asthma from a population-based cohort, 29.6% reported visible mould in the dwelling. Paucigranulocytic (reference category), neutrophilic, eosinophilic and mixed phenotypes ac…
- Publisher Full Text (DOI)
- Minimum important difference for the incremental shuttle walk test in long covid rehabilitation. [Journal Article]Thorax. 2026 Aug 05. [Online ahead of print]T
- The minimum important difference (MID) for the incremental shuttle walk test (ISWT) in individuals with long covid was estimated using anchor-based and distribution-based methods. 397 participants (56 ± 13 years; 63.7% male) with long covid completed a 6-week rehabilitation programme and rated perceived change using the Global Rating of Change Scale (GRCS). Change in ISWT distance differed across…
- Publisher Full Text (DOI)
- Breathing immunity into in vitro lung models. [Review]Thorax. 2026 Aug 05. [Online ahead of print]T
- CONCLUSIONS: Collectively, these advances pave the way for improved immune-competent lung models to accelerate therapeutic discovery and enhance model translational relevance.
- Publisher Full Text (DOI)
- Unsupervised home spirometry versus supervised clinic spirometry: analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis. [Journal Article]Thorax. 2026 Aug 05. [Online ahead of print]T
- CONCLUSIONS: Home spirometry demonstrates good agreement with clinic spirometry, with variability between measurements decreasing over time. Home spirometry detected changes in lung function across exacerbations, although variability may limit interpretation at the individual patient level. With appropriate patient support to maintain adherence, home spirometry has potential as a tool for remote monitoring and decentralised clinical trials in bronchiectasis.
- Publisher Full Text (DOI)
- Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial. [Journal Article]Thorax. 2026 Aug 05. [Online ahead of print]T
- CONCLUSIONS: DRA failure rate was low and did not identify medium-term/long-term tolerance to HTS, indicating that its utility as a screening tool for tolerability in this population is limited.
- Publisher Full Text (DOI)
- Inhaled and oral corticosteroid use and the risk of pulmonary aspergillosis: a Danish population-based case-control study. [Journal Article]Thorax. 2026 Jul 31. [Online ahead of print]T
- CONCLUSIONS: Our results demonstrate a strong and seemingly dose-dependent association between both systemic and inhaled corticosteroid use and aspergillosis.
- Publisher Full Text (DOI)
- Corticosteroids in COPD carry the danger of fatal aspergillosis. [Editorial]Thorax. 2026 Jul 31. [Online ahead of print]T
- Publisher Full Text (DOI)
- Secondary pulmonary alveolar proteinosis mimicking ILD progression in anti-MDA5 dermatomyositis. [Journal Article]Thorax. 2026 Jul 31. [Online ahead of print]T
- Publisher Full Text (DOI)
- Familial associations of lung function between parents, offspring and siblings: a two-generation study of the ECRHS and RHINESSA cohorts. [Journal Article]Thorax. 2026 Jul 29. [Online ahead of print]T
- CONCLUSIONS: This study supports phenotypic concordance of lung function within families, with the strongest positive association observed between mothers and sons. Approximately 75-80% of the variance of FEV1 and FVC was explained within-family.
- Publisher Full Text (DOI)
- Effect of maintenance macrolide de-escalation during the Australian summer on exacerbations of obstructive airway diseases: a randomised, double-blind, placebo-controlled trial. [Journal Article]Thorax. 2026 Jul 28. [Online ahead of print]T
- CONCLUSIONS: Macrolide de-escalation was not found to be non-inferior to continued treatment in individuals with OAD. While some patients may be able to discontinue long-term macrolide therapy during the summer, there remains a risk of exacerbation recurrence.
- Publisher Full Text (DOI)
- Air pollution and chronic obstructive pulmonary disease: beyond respiratory outcomes. [Editorial]Thorax. 2026 Jul 23. [Online ahead of print]T
- Publisher Full Text (DOI)
- Bidirectional association between visceral adiposity and obstructive sleep apnoea: longitudinal findings from the Wisconsin Sleep Cohort. [Journal Article]Thorax. 2026 Jul 23. [Online ahead of print]T
- CONCLUSIONS: The association between visceral adiposity and OSA is bidirectional and significant in young and middle-aged but not in older adults. Our findings suggest that visceral adiposity might be the target of preventative and therapeutic strategies for OSA.
- Publisher Full Text (DOI)
- Journal club. [Journal Article]Thorax. 2026 Jul 23. [Online ahead of print]T
- Publisher Full Text (DOI)